Cassava Sciences, Inc. (SAVA)
3.24
+0.04
(+1.25%)
USD |
NASDAQ |
Dec 09, 16:00
3.14
-0.10
(-3.09%)
Pre-Market: 09:24
Cassava Sciences EPS Diluted (Quarterly): -0.2237 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 3.171 |
| Geron Corp. | -0.0276 |
| Ovid Therapeutics, Inc. | -0.171 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.81M |
| Total Expenses (Quarterly) | 10.81M |
| Enterprise Value | 50.44M |
| Earnings Yield | -67.84% |
| Normalized Earnings Yield | -67.84 |